Choices and Experiences Around Closed-loop Therapy in Type 1 Diabetes
NCT ID: NCT07177404
Last Updated: 2025-09-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
100 participants
OBSERVATIONAL
2025-09-30
2026-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main purpose of this study is to explore the choices and experiences of people living with type 1 diabetes regarding closed-loop therapy.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Hybrid Closed Loop Systems in People With Type I Diabetes
NCT05348499
EFFECT OF HYBRID CLOSED-LOOP SYSTEMS ON CARDIOVASCULAR MARKERS IN TYPE 1 DIABETES.
NCT07241702
Closed Loop From Onset in Type 1 Diabetes
NCT02871089
24/7 Closed-loop in Older Subjects With Type 1 Diabetes
NCT04025762
Diabetes Closed-Loop Project 6 (DCLP6): Fully Automated Closed-Loop Control in Type 1 Diabetes Using Meal Anticipation
NCT04877730
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The primary objective of the study is to explore the factors driving the choices of people living with type 1 diabetes regarding closed-loop therapy.
The secondary objectives of the study are:
* To understand what treatment satisfaction with closed-loop therapy means to people living with type 1 diabetes
* To understand what additional support is needed for people with type 1 diabetes using closed-loop therapy
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Type 1 diabetes (any duration)
* People who use closed-loop therapy or wait to start closed-loop therapy or considering closed-loop therapy in the future
* Ability to give informed consent
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Nottingham
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospitals of Derby and Burton
Derby, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
25026
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.